We are live on
!
Find out more
BRM
Boston Research & Management Portfolio holdings
AUM
$453M
1-Year Est. Return
20.63%
This Fund
S&P 500
This Quarter
Est. Return
+11.83%
1 Year Est. Return
+20.63%
3 Year Est. Return
+53.69%
5 Year Est. Return
+69.59%
10 Year Est. Return
+264.58%
AUM
$240M
AUM Growth
+$30M
(+14%)
Cap. Flow
+$6.46M
Cap. Flow
% of AUM
2.69%
Top 10 Holdings %
Top 10 Hldgs %
25.18%
Holding
105
New
5
Increased
27
Reduced
32
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.58M |
| 2 |
CVS Health
CVS
|
+$670K |
| 3 |
General Mills
GIS
|
+$601K |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$455K |
| 5 |
Linde
LIN
|
+$351K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$384K |
| 2 |
Abbott
ABT
|
+$224K |
| 3 |
Fastenal
FAST
|
+$223K |
| 4 |
Mastercard
MA
|
+$222K |
| 5 |
Intel
INTC
|
+$189K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 17.53% |
| 2 | Technology | 14.55% |
| 3 | Industrials | 12.87% |
| 4 | Healthcare | 12.11% |
| 5 | Consumer Staples | 11.61% |
Similar funds
BFT
BAMG
CI
ACM
IP
FDS
BWA
WC
Boston Research & Management's Q1 2019 Portfolio in Review
As of Q1 2019, Boston Research & Management held 105 positions worth $240M, up 14% from $210M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Boston Research & Management's Q1 2019 filing shows 5 new, 27 increased, 32 reduced and 1 closed positions. Its largest new stake was Vanguard Morningstar Growth ETF: 10,230 shares worth $266K. The largest sale was Berkshire Hathaway Class B, an estimated $384K.
By sector, the portfolio is most concentrated in Miscellaneous at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.
- Boston Research & Management's largest Q1 2019 buy was Vanguard Morningstar Growth ETF: 10,230 shares worth $266K.
- Boston Research & Management added most to Walt Disney in Q1 2019, an estimated $2.58M increase.
- Boston Research & Management's biggest Q1 2019 reduction was Berkshire Hathaway Class B, cutting an estimated $384K.
- Boston Research & Management fully exited Alerian MLP ETF in Q1 2019, selling an estimated $168K.
- Boston Research & Management's ten largest holdings make up 25% of its $240M portfolio in Q1 2019.
- Boston Research & Management opened 5 new positions and closed 1 in Q1 2019.
- Boston Research & Management's portfolio value rose 14% quarter-over-quarter to $240M.
Based on Boston Research & Management's 13F filing for Q1 2019, filed 7 May 2019.